Condition
Comparing of 2 Different Volumes in ESPB in Patients Undergoing MRM
Total Trials
1
Recruiting
0
Active
0
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
2 treatments under study, led by Group 2high Concentrationlow Volumecbupivacaine Us Guided Erector Spinae Plane Block
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 1 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
1Total
Phase 2/3 (1)
Trial Status
Completed1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (1)
Research Network
Common Treatments
- Group 2high Concentrationlow Volumecbupivacaine Us Guided Erector Spinae Plane Block1
- Group 1low Concentrationhigh Volume Bupivacaine Us Guided Erector Spinae Plane Block1
Active Sponsors
- Cairo University1
- Yasmina sayed Abdrabo Ismael1
- Ahmed Shaker Ragab1
- Norhan Abdelaleem Ali1
Top Investigators
Cairo University